Willis Towers Watson (WTW) Q1 2025 earnings summary

Executive summary

• Achieved 5% organic revenue growth and 100 basis points of adjusted operating margin expansion in Q1 2025, with adjusted EPS of $3.13, despite a 5% reported revenue decline due to the TRANZACT sale.

• Strategic focus on efficiency, operating leverage, and margin expansion continues, with strong execution and robust segment performance in both HWC and R&B.

• Net income increased 23% to $239M, reflecting lower transformation and restructuring costs after the completion of the Transformation program.

• Returned $288 million to shareholders via $200 million in share repurchases and $88 million in dividends in Q1 2025.

• Maintains strong liquidity with $1.5 billion in cash and full access to a $1.5 billion revolving credit facility.

Financial highlights

• Q1 2025 revenue was $2.22B, down 5% year-over-year; organic revenue up 5%.

• Adjusted diluted EPS was $3.13, up 8% year-over-year excluding TRANZACT; diluted EPS rose 27% to $2.33.

• Free cash flow was negative $86 million in Q1, down $50 million year-over-year, mainly due to the TRANZACT divestiture and higher compensation payments.

• Adjusted operating margin: 21.6% in Q1 2025, up 100 bps year-over-year.

• Net income attributable to WTW: $239 million, up from $190 million year-over-year.

Outlook and guidance

• Reaffirmed 2025 outlook for mid-single-digit organic growth, adjusted operating margin expansion, adjusted EPS growth, and improved free cash flow margin.

• Share repurchases of ~$1.5B planned for 2025, subject to market and investment opportunities.

• R&B segment targeting ~100 bps average annual margin expansion over next 3 years; incremental margin expansion expected at HWC and enterprise levels.

• Free cash flow margin expected to expand for the full year, with Transact sale and transformation wind-down as tailwinds.

• Reinsurance JV with Bain Capital expected to be a $0.25–$0.35 headwind to adjusted diluted EPS.